Back to top

earnings-growth: Archive

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Ralph Lauren (RL)

Ralph Lauren (RL) could produce exceptional returns because of its solid growth attributes.

RLNegative Net Change

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why Western Digital (WDC) is a Solid Choice

Western Digital (WDC) could produce exceptional returns because of its solid growth attributes.

WDCPositive Net Change

Zacks Equity Research

Here is Why Growth Investors Should Buy Celestica (CLS) Now

Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

CLSPositive Net Change

Zacks Equity Research

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

HQYPositive Net Change

Zacks Equity Research

3 Reasons Why Growth Investors Shouldn't Overlook Quanta Services (PWR)

Quanta Services (PWR) could produce exceptional returns because of its solid growth attributes.

PWRPositive Net Change

Zacks Equity Research

Is Lincoln Electric (LECO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Lincoln Electric (LECO) could produce exceptional returns because of its solid growth attributes.

LECONegative Net Change

Zacks Equity Research

Permian Resources (PR) is an Incredible Growth Stock: 3 Reasons Why

Permian Resources (PR) possesses solid growth attributes, which could help it handily outperform the market.

PRPositive Net Change

Zacks Equity Research

Brokers Suggest Investing in Lowe's (LOW): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in Lowe's (LOW). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

LOWPositive Net Change

Zacks Equity Research

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CVSNegative Net Change

Zacks Equity Research

Is Applied Materials (AMAT) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Applied Materials (AMAT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

AMATPositive Net Change